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Abstract 
Family carers of people with motor neurone disease face many challenges pre and 
post-bereavement, with support needs not routinely assessed and little attention 
focused on recognising abnormal grief responses.  Our survey (n=56) sought the views 
of those involved in the care of this population in England on bereavement support 
and Prolonged Grief Disorder. Results revealed over two-thirds of respondents felt 
unable to predict future cases of Prolonged Grief Disorder and that an alert tool to help 
identify carers of people with motor neurone disease at risk would be welcomed.   
Implications for future research and development of support are discussed. 
 
Introduction 
Bereavement and Prolonged Grief Disorder 
Each year, globally, around 56,000,000 people die (WHO, 2012), with large numbers 
of the general population losing a ‘significant other’ (Stroebe et al, 2007, p.1960). 
Although there is acknowledgement that the effects of bereavement can be profound, 
it is also true that most people will grieve in a normal manner with their grief fading 
into adequate coping mechanisms within six months of bereavement (Segen, 2012).  
However, it is estimated between 10 and 20% of bereaved people will develop 
Prolonged Grief Disorder (PGD) (Middleton et al, 1996; Prigerson and Jacobs, 2001). 
There is variation in attempts to define PGD (Stroebe and Schut, 2006); here we adopt 
the suggestion that it refers to instances where: 
 
[t]he normal grief reaction lingers and becomes increasingly debilitating . . . people 
with PGD have intrusive thoughts and images of the deceased person and a painful 
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yearning for his or her presence.  They may also deny their loss, feel desperately 
lonely, and want to die themselves (Prigerson et al, 2009, p.12)   
 
Although commonalities exist with the experience of ‘normal’ bereavement, PGD 
health consequences are typically longer-lasting and more severe.  Alongside  
‘yearning, disbelief about the death, difficulty moving on and feeling detached, bitter 
and agitated about the death’ (Kristjanson et al, 2006, p.37), PGD symptoms have 
been associated with a range of physical and psychological health concerns and 
behaviours and reduced quality of life (Silverman et al, 2000; Jacobsen et al, 2006; 
Melhem et al, 2007; Prigerson et al, 2009; Rings et al, 2014), as well as increased 
health service use and absence from employment (Lannen, et al, 2008). 
 
Motor Neurone Disease and PGD 
Motor Neurone Disease (MND), a progressive terminal condition, is thought to result 
in the deaths of over 100,000 people, each year, worldwide 
(http://www.alsmndalliance.org/). MND has no known cure; the complex nature of 
the illness and rapid deterioration at end-of-life can be traumatic for carers unprepared 
for the final phase (Goldstein et al, 1998) and prognosis is poor, with average survival 
from diagnosis approximately 14 months. Carers of people living with MND 
(plwMND) have likened their experience of caring as akin to a series of bereavements 
with fragmented, poorly communicated and generally dissatisfying service provision 
meaning these carers are under considerable strain (Aoun et al, 2012). Additionally, 
the continuous losses associated with MND can be cumulative, reflecting the notion 
of pre-death grief recognised in dementia (Kiely et al, 2008). 
MND family carers, therefore, are potentially at greater risk of grieving in an 
unusually intense manner beyond the period typically considered normal. There is 
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little published research, however, identifying particular populations of carers, such 
as MND family carers, who might need additional bereavement-related support 
(Stroebe et al, 2006). The only published study to explore PGD in MND, conducted 
in Australia, reported a 37.5% incidence amongst carers (Aoun et al, 2012), which is 
substantially higher than that reported in the general population, though the sample of 
16 was small.  As it is unknown what bereavement support is available, or offered, to 
carers of plwMND and whether their bereavement support needs are being met, we 
undertook a study to explore experiences of bereavement support and awareness of 
PGD with health and social care professionals involved in the care of plwMND in 
England.   
 
Methods 
The study involved the distribution of an online survey, using Survey Monkey® 
software, to gather the views of health and social care professionals directly involved 
in the care of plwMND. University Faculty research ethical approval was granted in 
January 2014 and National Health Service (NHS) Research and Development (R&D) 
permissions from 16 trusts were secured between January and July 2014. 
Sampling was purposive and targeted at individuals with direct involvement with 
plwMND and included 20 MND Association Regional Care Development Advisors 
(RCDAs) in England who provide support and information to plwMND and their 
families, and 84 members of staff working in 16 MND Care and Research centres in 
England. Snowballing was encouraged with individuals prompted to share the survey 
link with others with experience of caring for plwMND (Procter et al, 2010). 
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Recruitment of respondents was via e-mail containing an embedded link to 
information about the study and access to the online survey.  The survey was available 
between February and July 2014 (access was necessarily staggered due to the varying 
dates on which trusts granted NHS permissions). A single e-mail reminder was sent 
to all potential participants two weeks after the initial contact (Oppenheim, 1992).  In 
total, the survey comprised 12 items, and included both closed and open-ended 
questions on areas including opinion and experience of bereavement support (pre and 
post-bereavement), experience of PGD, ability to predict PGD and suggestions for 
improving bereavement support.  
 
Analysis  
Closed question responses were analysed using simple descriptive statistics such as 
frequencies and percentages. Open text comments were analysed thematically (Braun 
and Clarke, 2006). Comments were read a number of times and initial codes applied. 
These codes were subsequently grouped into themes reflecting the participants’ 
opinions on MND family carers’ bereavement needs. To increase rigour, inter-rater 
techniques were adopted (Low, 2007) by which two members of the team initially 
conducted the thematic analysis independently before coming together to agree on 
emergent themes.   
 
Results 
The survey was intentionally distributed to 104 people and was completed by 56 
individuals: 12 (21%) respondents were MND Association RCDAs and 31 (55%) 
were staff working in MND Care and Research centres. An additional 10 respondents 
(18%) comprised of occupational therapists, physiotherapists, advanced neurology 
5 
 
nurses, and MND Association volunteer visitors; three respondents (5%) did not 
specify their role. These figures indicate response rates of 60% for MND Association 
RCDAs and 37% for MND Care and Research Centre staff.  Results from the closed 
response questions are presented in graph form to indicate the overall opinion of 
respondents.  Open text responses presented are regarded as exemplars indicative of 
the emergent themes and presented with anonymised identification codes assigned 
during analysis.  
 
Opinions of bereavement support 
Pre-bereavement support 
Participants were asked their views on bereavement-related support provided to MND 
family carers prior to bereavement. The majority rated support as average or worse, 
with less than a fifth (18%, n= 10) rating it as good or excellent (Figure 1).  
Respondents commented that difficulties in the provision of support occurred as a 
result of a lack of formal guidelines on available services: 
 
     ‘There are no formal guidelines about what we do/don’t offer.’ R29 
 
Similarly, uncertainty was apparent regarding the extent of available support services: 
 
‘The ‘whole’ range is not commonly known or knowledge of the range is not kept and 
coordinated in one central place.’ R28 
 
Whilst support was accessed, ‘alongside their loved one during the pre-bereavement 
process’ (R13), respondents were unclear how much emphasis on preparation for 
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bereavement was provided. It was felt that the provision of pre-death assessment could 
potentially identify those who might experience difficulties with their grief: 
 
‘The people who really struggle, however, are not always recognised prior to the 
death and may well flounder. Some pre-death assessment would help.’ R27 
 
[Insert Figure.1.] 
 
Post bereavement support  
When asked their opinion of post-bereavement support for MND family carers a 
majority (80%, n=45) rated it as average or worse (Figure 2.).  Respondents also 
believed that problems with accessing services, and waiting times experienced, 
needed to be addressed. Furthermore, it was apparent that most organisations were 
only providing minimal support:  
 
‘Most organisations seem to be offering minimal support following the death, often 
just a letter or telephone call, which leaves the bereaved person totally alone after 
being surrounded by professionals prior to the death.’ R27  
 
Whereas prior to bereavement many health/social care professionals are frequently 
present, carers are often left on their own following the death of a loved one. The 
effect of this sudden cessation of support was emphasised by a number of respondents: 
 
‘We look after the ‘team’ i.e. patients and carers and then when one dies we drop the 
other with little support at the most difficult time.’ R21  
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The support available from different organisations was regarded as too disjointed:   
 
‘Support is too fragmented so you are often unaware of who is doing what.  Hospices 
don’t often tell a health professional what they are doing with regard to bereavement 
support.’  R26 
 
A further problem was related to the way in which the needs of individuals are 
recorded. In some cases services might be offered by one organisation and declined 
as it was not the particular type of support that the carer was looking for.  However, 
this can lead to it being recorded that no bereavement services are required at all - and 
consequently no further alternative support offered - rather than the carer being 
informed of the range of bereavement services available to them. It was apparent from 
responses received that the bereavement needs of carers vary widely:  
 
‘Everyone grieves in different ways and therefore require different forms of 
bereavement support.’ R28   
 
With this in mind, respondents highlighted that variability in the type and amount of 
support provided was necessary, as was guidance on what to include: 
 
‘There is no “one size fits all”, although it would be useful to have some 
standards/guidelines about what should be offered at different stages.’ R14 
 
Respondents underlined that due to the ongoing nature of losses in MND, bereavement 
can be experienced over time as the disease progresses, often necessitating ongoing 
support for carers: 
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‘Bereavement is not only related to the death of a patient and it should be recognised 
and highlighted that for many carers and family members bereavement begins quite 
often at the time a patient is diagnosed or even before this.  We hear so often families 
and carers express they lost their family member way before the death - this is when 
we should be supporting these people.’ R28  
 
It was clear from the respondents’ comments that patient involvement with specialist 
palliative care services/hospices should equate to better bereavement support for 
carers: 
 
‘If patients access specialist palliative care services there is often much more support 
available for their family after death.’ R19 
 
In situations where the patient has not received specialist palliative care/hospice 
involvement, or has chosen not to access it, there was less likelihood that the family 
would be supported post-bereavement:  
 
‘With hospice support these [family bereavement needs] are usually well managed, 
where this is not available, this is less likely.’ R11  
 
[Insert Figure 2.] 
Experience of PGD 
To understand the possible extent of PGD amongst MND family carers, participants 
were questioned about their awareness of the condition. Forty-five per cent (n=24) felt 
they had encountered a family carer experiencing PGD (Figure 3):  
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[Insert Figure3.] 
A majority (70%, n=37) felt unable to accurately predict future occurrences of PGD 
(Figure 4) and 70% (n=37) believed that there was a need for a specific alert tool to 
help predict MND family carers at risk of developing PGD (Figure 5.): 
 
[Insert Figure 4.]  [Insert Figure5.] 
 
Open text comments indicated that training in recognition of the symptoms of PGD is 
required to empower and educate health and social care professionals:   
 
‘Training on early identification, support strategies and minimising risk of PGD 
occurring.’ R34 
 
It was also felt that up-to-date information on bereavement and PGD-related research 
studies should be distributed to health and social care professionals alongside the 
provision of information regarding available support for MND carers in respective 
localities:   
 
‘Inform multidisciplinary team members of the availability of services so they can be 
more efficiently signposted to ensure uptake from family post-bereavement.’ R20 
 
Additionally, one respondent suggested that ‘a one page sheet with tick boxes for 
predictive factor’ (R19) would be beneficial. 
 
As it is not currently possible to diagnose PGD until a minimum of six months post-
bereavement we were keen to know the duration of any post-bereavement support 
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made available to MND family carers. Many respondents (41%, n=23) were unaware 
of how long support was provided following a death and only 9% (n=5) reported it 
lasting more than six months.  As one respondent noted:  
 
     ‘I have little or no knowledge of what is offered post death.’ R21 
 
Discussion 
The provision of bereavement support for carers should be seen as an essential 
component of palliative care (Sepúlveda et al, 2002). Recent reports underline the 
increased attention being focussed upon addressing issues around bereavement 
support in the UK, including notions of how intense and long-lasting grief can best be 
assessed and treated (PeolcPSP, 2015); this is further emphasised in work conducted 
not only in wider Europe (Schut and Stroebe, 2005) but globally (Aranda and Milne, 
2000; Shear et al, 2011; He et al, 2014).    This study sought to examine such matters 
to provide a picture of current viewpoints and experiences, regarding bereavement 
support, of professionals in England involved in the care of people with MND.  
Results mirror those in other studies in suggesting that health and social care 
professionals hold mixed views on available bereavement support (Office for National 
Statistics, 2012).  Large numbers view both pre and post-bereavement support as 
below average though some (albeit a smaller proportion) did believe it to be good; this 
is again comparable with findings from other studies (Macmillan Cancer Support, 
2012).   
Our respondents generally reported being unfamiliar with the extent of bereavement 
services available, which resonates with previous research indicating deficiencies in 
professionals’ knowledge of the organisation of services, including counselling and 
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emotional support, for people affected by MND (Brown et al, 2005). There is clearly 
variability in the type and amount of support required, with carer needs being 
dependent on individual circumstances. Services for people affected by MND are 
often disjointed and vary considerably both in the UK and internationally (Down et 
al, 2005; Aoun et al, 2012; Franklin, 2014) – an inconsistency that potentially fosters 
widely differing carer experiences.  This reinforces the view that a range of support 
services should be provided from which MND carers can draw upon (O'Brien et al, 
2012), with greater attention focused on developing clear and targeted bereavement 
support (Aoun et al, 2012).  
It is known that patients with MND and their carers, are more receptive to a palliative 
approach to care than those affected by the vast majority of other neurological 
conditions (Kristjanson et al, 2006). However, the findings from this study again 
reflect other studies in reporting difficulties in accessing palliative care services 
(O’Brien et al, 2012) and limited and/or inconsistent palliative care involvement in 
end stage MND (Kristjanson et al, 2006). Our data suggest where patients are in 
receipt of specialist palliative care that bereavement support for carers is more likely 
to be offered. Nevertheless, more than half of those expected to die will not receive 
specialist palliative care and consequently their carers are unlikely to be offered timely 
bereavement support (Hudson and Payne, 2011). 
The literature points to a general PGD prevalence of between 10-20% (Prigerson and 
Jacobs, 2001); a suggestion of a higher incidence (37.5%) amongst MND family 
carers (Aoun et al, 2012) is supported by our data indicating that carers of plwMND 
may indeed be at greater risk of developing PGD than the general population. It is all 
the more concerning, then, that an overwhelming majority of our respondents felt 
unable to accurately predict future cases of PGD.  
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Those people likely to experience more severe and lasting consequences of 
bereavement need to be identified so that support can be targeted towards them 
(Stroebe et al, 2006) but our findings suggest that health and social care professionals 
require assistance in determining who may be at risk (Kristjanson et al., 2006). To 
date, many of the tools for measuring PGD have been used for the purposes of 
diagnosis only, assessing whether people meet the criteria for PGD, or specific 
adverse health outcomes, at a given point in time, usually six months following the 
death of the cared for person. When such criteria are met, it is recommended that a 
more formal assessment is then sought for the bereaved individual.  It is perhaps 
surprising, however, that little attention has been directed towards pre-death 
examination of complications with grief amongst carers (Tomarken et al, 2008).  
Having the capacity to accurately anticipate those most likely to experience PGD 
would clearly be of great value.  The importance of health and social care 
professionals having access to reliable and valid instruments is imperative if accurate 
assessment of the needs of family carers is to occur (Hudson et al, 2010). Our data 
indicates a need for a quick and easy-to-use alert tool to help professionals identify 
those potentially at risk of PGD. 
The effective use of an alert tool would enable the identification of those most likely 
to benefit from any available support and the signposting of individuals to the most 
appropriate intervention. Thus assessing for risk of PGD prior to bereavement might 
allow professionals to protect bereaved individuals from any future impairment 
(Guldin et al, 2011).  Furthermore, the identification of individuals at risk of 
developing PGD could be helpful, in combination with a formal clinical assessment, 
when allocating resources and provision of targeted support to the bereaved (Guldin 
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et al, 2011; Guldin et al, 2012).  As such, the potential utilisation of such a tool is the 
focus of current work by the authors. 
Nonetheless, the findings presented here must be considered in light of several 
limitations, the first of which is linked to the sampling strategy which, due to 
constraints within the regulatory system, required to obtain NHS permissions at the 
time, meant that some recruitment was via gatekeepers; it is not known whether the 
survey link was distributed as fully as hoped. Secondly, as survey responses were 
anonymised we were not able to analyse responses according to geographical location. 
It is possible, however, that views of services differed according to place of 
employment, reflecting variability in available bereavement services nationwide; this 
would be interesting to target in future research studies. Future studies might also 
consider a more in-depth exploration of the services as experienced by current and 
former carers including reasons for not accessing available services.   
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KEY POINTS 
 
• The complex nature of MND and rapid deterioration at end-of-life can be traumatic 
for family carers who liken their experiences as akin to a series of bereavements. 
Generally, between 10-20% of bereaved people will develop Prolonged Grief 
Disorder, but one study estimated the prevalence amongst MND family carers to be 
37.5%. It is important to assess and meet this population’s needs in bereavement, but 
routine assessment of these carers does not take place in practice. 
 
• The incidence of PGD amongst MND family carers appears to be at higher level 
than in the general population.  Health/social care professionals working with people 
with MND are uncertain of the most appropriate course of action to pursue to support 
carers in their bereavement and struggle to accurately predict MND family carers at 
risk of developing PGD. 
 
• The study highlights the importance of identifying MND family carers at risk of 
developing PGD so that targeted support can be initiated in a timely manner.  There 
is a need for a simple to use alert tool to help health/social care professionals to detect 
MND family carers at risk of developing PGD. 
